KXS TOR Week ended 07 Aug 2026

Weekly Investor Report

Kinaxis Inc. · Technology · Software - Application

Open interactive chart View report data
Latest close 173.4 CAD
3.2% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 18.4% above the Trend Line and sits at 67.1% of its 52-week range. The latest completed week returned 3.2%, after a 12.0% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 61/100.

Setup score 50 out of 100
Latest Close 173.4 CAD 7 Aug 2026
1W Return 3.2% latest completed week
4W Return 12.0% short-term follow-through
12W Return 24.9% quarterly tape
Trend Breadth 19.2% 10 of 52 weeks active
Volume Ratio 1.3x vs 13-week average
What is working
  • The trend backdrop is active with a 4-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 41.95% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 3.2% Latest completed week; four-week move 12.0%. Indicator stack 24/74 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 41.95% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 61/100 18 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 18.4% above the Trend Line and sits at 67.1% of its 52-week range. The latest completed week returned 3.2%, after a 12.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4612-week average 0.31

12-week confirmation

Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.46Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 12.0% over four weeks, 24.9% over 12 weeks, and -13.1% over one year. The current trend has remained active for 4 consecutive weeks.

Performance by holding period

1W3.2%
4W12.0%
12W24.9%
26W36.1%
52W-13.1%
Active trend streak4 weeks
Active weeks in one year10
Trend breadth19.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.86Latest activity-pressure read.
Pressure change108.4%Four-week change in activity pressure.
Leadership-4.84Latest relative-leadership reading.
RS change70.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 88% Model confidence 82%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength12/100Blend of value, momentum, and quality. Underlying universe rank 89; rank 1 is best.
Value3/100Relative valuation strength. Underlying universe rank 98; rank 1 is best.
Quality99/100Profitability and accounting quality. Underlying universe rank 2; rank 1 is best.
Momentum10/100Medium-term price momentum. Underlying universe rank 91; rank 1 is best.
Growth74/100Revenue and earnings growth. Underlying universe rank 27; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
56.6x
Price divided by trailing earnings.
Price / sales
8.1x
Market value relative to trailing revenue.
EV / EBITDA
37.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
3.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
66.0%
Gross profit retained from each unit of revenue.
Operating margin
17.4%
Operating profit retained from revenue.
Free-cash-flow margin
23.7%
Free cash flow generated from revenue.
Return on invested capital
36.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
13.4%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
18.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
9/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
2.2%
Net share repurchases relative to market value.
Shareholder yield
2.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment61/100

Weighted news tone is positive across 18 relevant articles.

5 positive · 13 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-13.7%Distance below the 52-week high.
13-week volatility7.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+13.8%Week of 31 Jul.
Worst week-12.5%Week of 15 May.
Latest week+3.2%Week of 7 Aug.

Shape of recent returns

Strong gains10
Modest gains5
Flat weeks0
Modest losses6
Sharp losses5
Recent vol7.0%13-week weekly-return volatility.
Base vol5.2%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew4.6% / -3.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape42/100

Trend, activity pressure, participation, and risk combine to a 42/100 tape read.

 Indicator analysis46/100

Latest 12-week confirmation: trend 4/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.46; No reversal markers Next-Week ExpectancyNegative 41.95%

Next-week expectancy is negative with a 41.95% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors31/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 15; Small Cap Core rank 97 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment61/100

Weighted news tone is positive across 18 relevant articles.

Kinaxis (TSX:KXS) Lifts Guidance On Strong Q2, Is The AI Upside Already Priced In? Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026173.4 CAD3.2%146.5 CAD162.7 CAD0.86-4.84405.7KOn
31 Jul 2026168.0 CAD13.8%146.6 CAD162.7 CAD0.73-5.68592.0KOn
24 Jul 2026147.6 CAD-4.5%146.7 CAD162.7 CAD0.51-18.32409.2KOn
17 Jul 2026154.5 CAD-0.2%147.7 CAD162.9 CAD0.52-15.31249.0KOn
10 Jul 2026154.8 CAD-0.9%148.4 CAD163.1 CAD0.41-16.20345.4KOff
3 Jul 2026156.3 CAD1.0%149.0 CAD163.3 CAD0.45-16.1410.6KOff
26 Jun 2026154.7 CAD5.7%149.6 CAD163.4 CAD0.58-17.2495.5KOff
19 Jun 2026146.5 CAD-10.4%150.3 CAD163.6 CAD0.70-22.5067.8KOff
12 Jun 2026163.5 CAD-1.9%151.3 CAD163.8 CAD0.82-14.40127.1KOff
5 Jun 2026166.8 CAD6.3%151.6 CAD164.0 CAD0.77-12.26154.0KOff
29 May 2026156.9 CAD7.3%152.0 CAD164.0 CAD0.77-19.05486.8KOff
22 May 2026146.2 CAD5.3%152.4 CAD164.2 CAD0.70-24.69488.4KOff
15 May 2026138.9 CAD-12.5%153.5 CAD164.4 CAD0.61-27.92591.0KOff
8 May 2026158.7 CAD9.7%154.9 CAD164.7 CAD0.54-19.17576.7KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context